Startups
Edit
ITM
http://www.itm.ag/Last activity: 11.06.2024
Active - Reference to ITM Isotope Technologies Munich SE
Overview
Employees
51-200
Total raised
$138.88M
Founded date
2004
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 22, 2021 | Funding round | $108.46M |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 9, 2021 | ITM to Host Virtual Symposium at the ESMO Congress 2021 with Key Neuroendocrine Tumor Experts on September 17, 2021 | ITM AG, a leading radiopharmaceutical company, today announced that it will host a virtual industry satellite symposium titled, “A Global Perspective on the Management of Neuroendocrine Tumors – the Evolving Role of Targeted Radionuclide Di... |
| Jun 10, 2021 | ITM : Announces EUR 25 Million (USD 30 M) Private Equity Financing to Support Advancement of Proprietary Precision Oncology Pipeline | ITM AG, a leading radiopharmaceutical company, announced today the close of a private equity financing round from existing and new investors, related and connected parties to Portland Holdings, along with FRIBA Investment, raising a total o... |
| May 20, 2021 | ITM to Host Virtual Symposium on “New Approaches for Targeted Radionuclide Therapy in Precision Oncology” with Key Opinion Leaders on Friday, June 4th, 2021 in Parallel to 2021 ASCO Annual Meeting | ITM AG, a leading radiopharmaceutical company, today announced that it will host a virtual symposium titled, “New Approaches for Targeted Radionuclide Therapy in Precision Oncology” as an ancillary event in parallel to the 2021 American Soc... |
| May 6, 2021 | ITM : Establishes Subsidiary in Shanghai to Accelerate Introduction of Its Precision Oncology Portfolio in China | ITM AG, a leading radiopharmaceutical company, today announced the establishment of a Chinese subsidiary, ITM (Shanghai) Precision Medical Co., Ltd., in Shanghai, China. The new subsidiary will be part of the ITM Group as a wholly foreign-o... |
| Apr 22, 2021 | ITM : Raises EUR 90 M (USD 109 M) to Accelerate Precision Oncology Pipeline and Support Ongoing Phase 3 Clinical Program | ITM AG announced today the successful close of a convertible loan financing totaling EUR 90 million (USD 109 million) led by Petrichor Healthcare Capital Management with participation of additional undisclosed investors. The proceeds will s... |
| Apr 22, 2021 | ITM Closes Convertible Loan Financing Totaling EUR90M | ITM, a Munich, Germany-based leader in precision oncology and the field of Targeted Radionuclide Therapy, closed a convertible loan financing totaling €90m (USD 109m). The round was led by Petrichor Healthcare Capital Management with partic... |
| Apr 10, 2021 | ITM : Presents Design for Ongoing Phase III COMPETE Trial with n.c.a. 177Lu-Edotreotide at AACR Annual Meeting 2021 | ITM AG today announced the presentation of a trial-in-progress poster highlighting its ongoing Phase III trial COMPETE with n.c.a. 177Lu-Edotreotide in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) at the virtual Ame... |
| Isotopen Technologien München | “ITM Isotopen Technologien M” |
Reviews 0
FAQ about ITM
When was ITM founded?
ITM was founded in 2004.
How much funding has ITM raised?
ITM has raised $138.88M in total across 2 funding rounds.
What funding rounds has ITM raised?
Parsers VC lists 2 funding rounds of ITM, among them a funding round of $108.46M on Apr 22, 2021.
What has the press written about ITM?
Parsers VC has collected 9 articles mentioning ITM, among them “ITM to Host Virtual Symposium at the ESMO Congress 2021 with Key Neuroendocrine Tumor Experts on September 17, 2021” (Sep 9, 2021) and “ITM : Announces EUR 25 Million (USD 30 M) Private Equity Financing to Support Advancement of Proprietary Precision Oncology Pipeline” (Jun 10, 2021).
Is ITM still active?
Yes, ITM is active; its latest activity on Parsers VC dates from Jun 11, 2024.